Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. US Specialty Formulations LLC
FDA Inspection
•US Specialty Formulations LLC•March 26, 2025

US Specialty Formulations LLC – FDA Inspection, Mar 26, 2025

Record Details

This FDA Inspection record concerns US Specialty Formulations LLC, with an inspection on March 26, 2025, issued by the Philadelphia District Office, covering human drugs.

Company
US Specialty Formulations LLC
Inspection Date
March 26, 2025
Product Type
Human Drugs
Office
Philadelphia District Office
People
  • Christina K. Theodorou (FDA Associated Person)
  • Lu Chen (Investigator)
  • Nabihah Amatullah (Issuing Officer)
View Company Profile

ID · e25bcef3-888a-4f3e-b64b-223257e43fa2

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1265449
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

5
  1. 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
  4. 21 CFR 211.22(d)Procedures not in writing, fully followed
  5. 21 CFR 211.100(a)Absence of Written Procedures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of US Specialty Formulations LLC

7
DateClassificationOfficeProject area
January 14, 2026Not classifiedPhiladelphia District OfficeDrug Quality Assurance
July 2, 2024OAIDrug Quality Assurance
April 26, 2022OAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
July 23, 2019OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 29, 2017OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for US Specialty Formulations LLC
  • FDA Inspection 1298396 - 2026-01-14
  • FDA Inspection 1243882 - 2024-07-02
  • FDA Inspection 1167934 - 2022-04-26
  • FDA Inspection 1097950 - 2019-07-23
  • FDA Inspection 1023411 - 2017-08-29

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore US Specialty Formulations LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.